Infoblox Inc. (BLOX) shares are surging 12.5% to $23.80 on Friday, after analysts at Citigroup (C) upgraded the stock to ‘Buy’ from ‘Neutral’. Ticker was also upgraded to ‘Market Outperform’ at JMP Securities. The firm rased the name’s price target to $29 from $23 implying 26% expected return.
On valuation measures, Infoblox Inc. shares currently have a PEG and forward P/E ratio of 4.68 and 60.86, respectively. Price/Sales for the same period is 4.67 while EPS is ($0.59). Currently there are 6 analysts that rate BLOX a ‘Buy’, 7 rate it a ‘Hold’. No analyst rates it a ‘Sell’. BLOX has a median Wall Street price target of $23.00 with a high target of $25.00.
In the past 52 weeks, shares of Santa Clara, California-based automated network control solutions developer have traded between a low of $11.67 and a high of $25.00. Shares are down 11.06% year-over-year ; up 5.05% year-to-date.
Shares of Mobileye N.V. (MBLY) were upgraded to an ‘Outperform’ rating from ‘Market Perform’ by Raymond James on Friday.
Mobileye N.V., currently valued at $5.32 billion, has a median Wall Street price target of $54.50 with a high target of $66.00. Approximately 4.83 million shares have already changed hands, compared to the stock’s average daily volume of 2.23 million.
In the past 52 weeks, shares of the Jerusalem, Israel-based company have traded between a low of $31.11 and a high of $60.28 with the 50-day MA and 200-day MA located at $37.76 and $43.98 levels, respectively. Additionally, shares of MBLY trade at a P/E ratio of 1.43 and have a Relative Strength Index (RSI) and MACD indicator of 40.06 and -0.38, respectively.
MBLY currently prints a one year loss of 3.92% and a year-to-date loss of around 12%
Shares of Acura Pharmaceuticals, Inc. (ACUR) are up nearly 13% in mid-day trading after analysts at MLV & Co. upgraded their ACUR rating to ‘Buy’ from ‘Hold’ and set a $1 price target. The firm said the upgrade was based on FDA’s recent acceptance of a NDA for ALO-02.
ACUR shares recently gained $0.10 to $0.86. The stock is down more than 60% year-over-year and has gained roughly 69% year-to-date. In the past 52 weeks, shares of Palatine, Illinois-based specialty pharmaceutical firm have traded between a low of $0.41 and a high of $2.10.
Acura Pharmaceuticals, Inc. closed Thursday at $0.76. The name currently has a total market cap of $42.01 million.
Aruba Networks, Inc. (ARUN) was reiterated as ‘Overweight’ by Barclays analysts on Friday. The broker also raised its price target on the stock to $28 from $22.
Aruba Networks shares recently gained $1.48 to $24.09. In the past 52 weeks, shares of Sunnyvale, California-based company have traded between a low of $15.65 and a high of $24.48. Shares are up 8.70% year-over-year and 24.37% year-to-date.
Northern Oil and Gas, Inc. (NOG) was reiterated as ‘Outperform’ with a $10 from $9 price target on Friday by RBC Capital Markets.
NOG shares recently gained $0.50 to $8.66. RBC’s target price suggests a potential upside of about 16% from the company’s current stock price.
In the past 52 weeks, shares of the New York-based firm have traded between a low of $4.79 and a high of $17.43. Shares are down 48.12% year-over-year ; up 44.42% year-to-date.
Leave a Reply